SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Guilford (GLFD) - Steadily Rising
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
496 22 0 GLFD
Emcee:  Jim Ball Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4714 PIII, plus several others... <<Guilford anticipates approximately 900 pMiljenko Zuanic-5/10/2004
470Loss Widens at Guilford Pharma By Robert Steyer TheStreet.com Staff Reporter 5Doc Bones-5/10/2004
469>>BALTIMORE, May 10 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals, Intuck-5/10/2004
468I just found this board...only to find all you guys from the valuation thread...zeta1961-5/7/2004
467>>BALTIMORE, April 1 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Intuck-4/1/2004
466Rights to NAALADase Inhibitor Technology Returned to Guilford; Pfizer Terminatesnigel bates-3/30/2004
465Guilford Pharmaceuticals (GLFD-NNM) by IRG Research (7.93, Feb. 27) Initiating wmopgcw-3/7/2004
464<<"I'm not 100% objective, but I try to be objective, especially Miljenko Zuanic-1/1/2004
463GLFD is in Ron Garren's model portfolio. In his year-end recap of the stockJMarcus-1/1/2004
462Guilford Pharmaceuticals Looks Up Optimism Is Demonstrated By Four Who Paid $54Doc Bones-12/31/2003
461small beans, but a vote nonetheless..ON 12/16/03, BRENNAN JOHN P, VICE PRESIDENTmopgcw-12/18/2003
460Joseph: I owned the stock because of the large-market potential of the developmscaram(o)uche-11/19/2003
459Rich, I am a bit concerned by your last statement. Can you please give Joseph Silent-11/19/2003
458Ha! Thanks for finding that. I *knew* that it was coming....... could feel itscaram(o)uche-11/19/2003
457>>Clinical Cancer Research Vol. 9, 5370-5379, November 1, 2003 Experimenttuck-11/19/2003
456>>BALTIMORE, Nov. 6 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inctuck-11/6/2003
455Guilford Pharmaceuticals Acquires U.S. Rights to AGGRASTAT(R) From Merck & Cmopgcw-10/29/2003
454can't find the release yet, but GLFD buys AGGRASTAT from Merck.scaram(o)uche-10/29/2003
453no direct relevance, that I know of, to anything ongoing at GLFD. Just parking (scaram(o)uche-10/22/2003
452Aug CC part 2: CRAIG SMITH, GUILFORD PHARMACEUTICALS - CHAIRMAN, PRES. & Cmopgcw-10/21/2003
451Final Event Transcript of GLFD conference call, 6-Aug-03 11:00am 2003-08-07 14:1mopgcw-10/21/2003
450Curr Drug Target CNS Neurol Disord. 2003 Oct;2(5):279-91. Poly(ADP-Ribosyl)atscaram(o)uche-10/8/2003
449kudospharma.co.uk Cancer Res. 2003 Sep 15;63(18):6008-15. Radiosensitizationscaram(o)uche-10/7/2003
448J Clin Invest. 2003 Oct;112(7):1049-57. Inhibition of GAPDH activity by poly(scaram(o)uche-10/7/2003
447Research Grants Totaling $5.7 Million Awarded for Evaluation of Guilford Pharmacscaram(o)uche-9/23/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News